FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/03/040715 [Registered on: 02/03/2022] Trial Registered Prospectively
Last Modified On: 27/04/2023
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmeceuitcal ]  
Study Design  Single Arm Study 
Public Title of Study   Safety and efficacy assessment of Product on skin 
Scientific Title of Study   PRIMARY OBJECTIVE To evaluate the in-vivo efficacy and safety of a skin care formulation in terms of even skin tone, reduction in pigmentation (dark spot)& radiant skin on healthy male & female subjects. SECONDARY OBJECTIVE To evaluate the in-vivo efficacy of a skin care formulation in terms signs of ageing: minimize fine lines, smooth skin texture, reducing dark circles and improvement in hydration on healthy male & female subjects  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
XXX-NF08-KD-JR22; Version: Final 01; Dated: 15/02/2022  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Raji Patil 
Designation  Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel West, Mumbai. MAHARASHTRA 400013 India

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Raji Patil 
Designation  Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel West, Mumbai. MAHARASHTRA 400013 India

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Public Query
 
Name  Mr Mohit Lalvani 
Designation  Study Director 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel West, Mumbai. MAHARASHTRA 400013 India

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  mohit@mascotspincontrol.in  
 
Source of Monetary or Material Support  
Mascot Spincontrol India Pvt. Ltd. 
 
Primary Sponsor  
Name  Kama Ayurveda Pvt Ltd  
Address  3 K Commercial Circle, Jungpura Extension, New Delhi – 110014  
Type of Sponsor  Other [Indian FMCG] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  Not applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Raji Patil  Mascot Spincontrol India Pvt. Ltd.   Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel West, Mumbai. MAHARASHTRA 400013 India
Mumbai
MAHARASHTRA 
02243349191

raji@mascotspincontrol.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethos- An Institutional Ethics committee (Mumbai)   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Volunteers with dull skin, pigmentary spots, crow’s feet wrinkles, uneven skin, under eye dark circle, Fitzpatrick skin type III to V 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  KMBF Face oil (KMBF – VR 01) : Product A  Approximately 4-5 drops of the Product will be applied once in a day on whole face. for period of 28 days. 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1. Having dull skin and uneven skin tone
2. Having pigmentary spot on the face of grade 2 to grade 6 according to the Bazins atlas
3. Having Crows feet wrinkle of grade 2 and above according to the Bazins atlas
4. Having visible under eye dark circle
5. Presenting Fitzpatrick skin type III to V with chromameter i.e. ITA° value between -30° &
41° on cheek bones.
 
 
ExclusionCriteria 
Details  1. Having started, changed or interrupted one hormonal treatment during the past 3 months
2. Having started, changed or stopped her tobacco consumption in the previous 6 months
3. Having consumed caffeine-based products, alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements
4. Having taken a medicinal treatment which could lead to hyper pigmentation in the previous 6 months
5. Taking oral supplements with major or minor effect on whitening of skin
6. Having had beauty treatment e.g. skin cleansing, exfoliation, scrub, mask or having applied self tanning products in the week preceding the start of the study
7. Having applied products with anti-wrinkle action in the 2 weeks preceding the start of the study
8. Having applied products with a depigmenting/ whitening action in the 4 weeks preceding the start of the study
9. Having undergone physical and/or chemical treatments of the spots in the previous 6 months
10. Having a suntanned skin on the studied areas which could interfere with the evaluations of the study For males, having not shaved their beard 24 hours prior to the day of measurement 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Even skin tone,
reduction in pigmentation (dark spot), radiant skin and skin brightness, safety of a skin 
Baseline, 14 days and 28 days  
 
Secondary Outcome  
Outcome  TimePoints 
Minimize fine
lines, smooth skin texture, reducing dark circles and improvement in skin hydration 
baseline, 14 days and 28 days  
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "33"
Final Enrollment numbers achieved (India)="33" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/03/2022 
Date of Study Completion (India) 18/05/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Objective: 

PRIMARY OBJECTIVE To evaluate the in-vivo efficacy and safety of a skin care formulation in terms of even skin tone, reduction in pigmentation (dark spot), radiant skin and skin brightness on healthy male & female subjects.

SECONDARY OBJECTIVE To evaluate the in-vivo efficacy of a skin care formulation in terms signs of ageing: minimize fine lines, smooth skin texture, reducing dark circles and improvement in skin hydration on healthy male & female subjects

Duration of study: 28 days study 

Kinetics: T0, T+14 days and T+28 days 

Population: 36 (18 Females & 18 Males) volunteers

The evaluation is performed using: 

1. Subject’s Self Evaluation, 

2. Dermatological Evaluation: Cosmetic Acceptability, 

3. Dermatological Evaluation: Efficacy 

4. Chromametry

5. Corneometry

6. CLBT (Color, Luminosity, Brightness, Transparency)

7. Cutometry

8. Tewametry

9. Sebumetry

10.  Mexametry

11.  Illustrative photographs of whole face & ¾ th face under diffused light

 
Close